What Drug Pricing Reform Means for Innovation and Access

In a recent article from GoBankingRates spotlighting the potential effects of President Trump’s executive order on drug pricing, Project Farma CEO Anshul Mangal weighed in on what’s at stake for both patients and the biotech industry.

While efforts to reduce out-of-pocket costs are gaining momentum, Anshul emphasized the need for thoughtful policy execution.

Ultimately, the industry will need to work closely with regulators to ensure reforms achieve the intended balance.

Read the full article, Ways Trump’s Prescription Drug Order Could Impact the Middle Class here.